Your browser doesn't support javascript.
loading
Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase.
Koda, Toru; Namba, Akiko; Kinoshita, Makoto; Nakatsuji, Yuji; Sugimoto, Tomoyuki; Sakakibara, Kaori; Tada, Satoru; Shimizu, Mikito; Yamashita, Kazuya; Takata, Kazushiro; Ishikura, Teruyuki; Murata, Syo; Beppu, Shohei; Kumanogoh, Atsushi; Mochizuki, Hideki; Okuno, Tatsusada.
Afiliación
  • Koda T; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Namba A; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Kinoshita M; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Nakatsuji Y; Department of Neurology, Toyama University Hospital, Toyama, Japan.
  • Sugimoto T; Graduate School of Data Scinece, Shiga University, Shiga, Japan.
  • Sakakibara K; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Tada S; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Shimizu M; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Yamashita K; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Takata K; Department of Neurology, Hoshigaoka Medical Center, Hirakata, Osaka, Japan.
  • Ishikura T; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Murata S; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Beppu S; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Kumanogoh A; Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Osaka, Japan. kumanogo@imed3.med.osaka-u.ac.jp.
  • Mochizuki H; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. hmochizuki@neurol.med.osaka-u.ac.jp.
  • Okuno T; Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. okuno@neurol.med.osaka-u.ac.jp.
J Neuroinflammation ; 17(1): 82, 2020 Mar 13.
Article en En | MEDLINE | ID: mdl-32169103
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Semaforinas / Células Th17 / Inflamación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Neuroinflammation Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Semaforinas / Células Th17 / Inflamación Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Neuroinflammation Asunto de la revista: NEUROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón